看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 193.9x - 214.4x | 204.1x |
| Selected Fwd Ps Multiple | 235.8x - 260.6x | 248.2x |
| Fair Value | $4.77 - $5.27 | $5.02 |
| Upside | -38.7% - -32.2% | -35.4% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| CVRx, Inc. | - | NasdaqGS:CVRX |
| OrthoPediatrics Corp. | - | NasdaqGM:KIDS |
| REMSleep Holdings, Inc. | - | OTCPK:RMSL |
| DexCom, Inc. | - | NasdaqGS:DXCM |
| Hyperfine, Inc. | - | NasdaqGM:HYPR |
| Daxor Corporation | - | NasdaqCM:DXR |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| CVRX | KIDS | RMSL | DXCM | HYPR | DXR | |||
| NasdaqGS:CVRX | NasdaqGM:KIDS | OTCPK:RMSL | NasdaqGS:DXCM | NasdaqGM:HYPR | NasdaqCM:DXR | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 52.3% | 23.1% | NM- | 22.3% | NM- | -20.6% | ||
| 3Y CAGR | 57.9% | 27.8% | NM- | 18.1% | 105.0% | -24.5% | ||
| Latest Twelve Months | 30.5% | 37.6% | -42.5% | 11.3% | 16.8% | -26.7% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -204.0% | -18.8% | -816.5% | 15.0% | -2078.0% | 734.4% | ||
| Prior Fiscal Year | -104.8% | -14.1% | -872.7% | 14.9% | -401.0% | 171.7% | ||
| Latest Fiscal Year | -116.9% | -18.5% | -919.9% | 14.3% | -315.9% | 448.0% | ||
| Latest Twelve Months | -116.9% | -18.5% | -919.9% | 14.3% | -315.9% | 448.0% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -1.8x | -50.6x | -18.1x | 32.1x | -0.5x | NA | ||
| Price / LTM Sales | 3.1x | 2.5x | 115.1x | 6.5x | 4.7x | 320.3x | ||
| LTM P/E Ratio | -2.7x | -13.6x | -12.5x | 45.5x | -1.5x | 71.5x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 2.5x | 4.7x | 115.1x | |||||
| Historical LTM P/S Ratio | 150.4x | 170.4x | 320.3x | |||||
| Selected Price / Sales Multiple | 193.9x | 204.1x | 214.4x | |||||
| (x) LTM Sales | 0 | 0 | 0 | |||||
| (=) Equity Value | 23 | 24 | 26 | |||||
| (/) Shares Outstanding | 4.9 | 4.9 | 4.9 | |||||
| Implied Value Range | 4.71 | 4.95 | 5.20 | |||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 4.71 | 4.95 | 5.20 | 7.77 | ||||
| Upside / (Downside) | -39.4% | -36.3% | -33.1% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | CVRX | KIDS | RMSL | DXCM | HYPR | DXR | |
| Value of Common Equity | 159 | 516 | 13 | 26,216 | 60 | 38 | |
| (/) Shares Outstanding | 26.0 | 24.8 | 1,523.6 | 392.1 | 77.8 | 4.9 | |
| Implied Stock Price | 6.11 | 20.77 | 0.01 | 66.86 | 0.77 | 7.77 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 6.11 | 20.77 | 0.01 | 66.86 | 0.77 | 7.77 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |